|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Implications of recent clinical trials for the National Cholesterol Education Program Adult Panel Ⅲ Guidelines显示文摘 | Grandy SM Cleeman JI Merz CN | 2004 | J Am Coil Cardiol2004，44，： | 1 |
| 2 | Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk显示文摘 | Ridker PM Wilson PWF Grandy SM | 2004 | Circulation2004，109，23： | 1 |
| 3 | Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation显示文摘 | Tomas SM Grandis JR | 2004 | Cancer Treat Rev2004，30，3： | 1 |
| 4 | Meta-analysis of efficacy and safety of new oral anticoagulants(dabigatran,rivaroxaban,apixaban)versus warfarin in patients with atrial fibrillation显示文摘 | Miller CS Grandi SM Shimony A | 2012 | Am J Cardiol2012，110，3： | 1 |
| 5 | Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apix- aban) versus warfarin in patients with atrial fibrillation显示文摘 | Miller CS Grandi SM Shimony A | 2012 | Am J Car- diol2012，110，3： | 1 |
| 6 | Cholesterol and coronary heaxt diease显示文摘 | | 1990 | JAMA1990，260，： | 1 |
| 7 | Hypertriglyceridemia insulin resistance and the metabolic syndrome显示文摘 | Grandy SM | 1999 | Am Cardiol1999，83，： | 1 |
| 8 | Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation显示文摘 | Miller CS Grandi SM Shimony A | 2012 | Am J Cardiol2012，110，3： | 1 |
| 9 | Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells显示文摘 | homas SM Grandis JR Wentzel AL | 2005 | Neoplasia2005，7，4： | 1 |
| 10 | The metabolism syndrome显示文摘 | Eckle RH Grandy SM Zimmet PZ | 2005 | Lancet2005，365，9468： | 1 |
| 11 | Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis:a systematic review 显示文摘 | Wu CQ Grandi SM Filion KB | 2013 | B JOG2013，120，7： | 1 |
| 12 | Meta-analysis of efficacy and safety of new oral anticoagulants ( dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation 显示文摘 | Miller CS Grandi SM Shimonv A | 2012 | Am J Cardiol2012，110，3： | 1 |
| 13 | Cholesterol and coronary heart diease 显示文摘 | Grandy SM | 1990 | JAMA1990，260，： | 1 |
| 14 | Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation显示文摘 | Miller CS Grandi SM Shimony A | 2012 | Am J Cardiol2012，110，3： | 1 |
| 15 | Treatment of dyslipidemia in NIDDM with Lovastatin显示文摘 | Grag A Grandy SM | 1988 | Am J Cardiol1988，309，： | 1 |
| 16 | Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation显示文摘 | Thomas SM Grandis JR | 2004 | Cancer Treat Rev2004，30，3： | 1 |
| 17 | HMG COA reductase inhibitors for treatment of hypercholesterolemia显示文摘 | Grandy SM | 1988 | N Engl J Med1988，319，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员